CU6 4.46% $6.21 clarity pharmaceuticals ltd

Ann: First patient treated in theranostic prostate cancer trial, page-5

  1. 5,966 Posts.
    lightbulb Created with Sketch. 517
    heading to 0cps. why even bother ipo???
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.